What question did this study set out to answer?

The aim is to explore how integrated multiomics approaches advance precision oncology and improve clinical outcomes.

January 23, 2026CancersOpen Access

Integrated and Comprehensive Diagnostics: An Emerging Paradigm in Precision Oncology

View Full Paper

Ask AI

Bookmark

Authors

KDKakoli DasTan Tock Seng Hospital JSJens SamolJohns Hopkins University IKIrfan Sagir Khan

Discussion

Member takes

Implication

This review demonstrates the integration of multiomics to improve treatment outcomes in oncology, suggesting broader implementation in clinical practice.

Key Points

The aim is to explore how integrated multiomics approaches advance precision oncology and improve clinical outcomes.
Reviewing recent advancements in molecular pathology
Analyzing large-scale consortia data like TCGA and CPTAC
Evaluating clinical outcomes from initiatives like NCI-MATCH trial
Discussing the integration of molecular data with functional outcomes
Multiomics reveals important tumour biology and behaviour
Treatment strategies guided by molecular profiling improve progression-free survival
Genomic analysis alone is insufficient for targeted therapy
Emerging mechanisms of therapeutic resistance are identified through multiomics

Cite This Study

Das et al. (2026) studied this question.

synapsesocial.com/papers/69730f59c8125b09b0d1f238 https://doi.org/10.3390/cancers18020327

View Full Paper

Ask AI

Bookmark

Implication

This review demonstrates the integration of multiomics to improve treatment outcomes in oncology, suggesting broader implementation in clinical practice.

Integrated and Comprehensive Diagnostics: An Emerging Paradigm in Precision Oncology

Discussion

Member takes

Implication

Key Points

Cite This Study

Integrated and Comprehensive Diagnostics: An Emerging Paradigm in Precision Oncology

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider